Clinical utility of an optoelectronic imaging tracing system for diagnosis of high-grade cervical lesions - Report - MDSpire

Clinical utility of an optoelectronic imaging tracing system for diagnosis of high-grade cervical lesions

  • By

  • Qianjiao Guo

  • Lixin Liu

  • Xiaomin Niu

  • Haifeng Qiu

  • Hongjun Guo

  • Wei Feng

  • Chunfang Wang

  • Liya Liu

  • Zheying Liu

  • Liping Han

  • June 10, 2026

  • 0 min

Share

Clinical Report: Efficacy of an Optoelectronic Imaging Tracing System for Identifying High-Grade Cervical Lesions

Overview

{'sensitivity': '97.6% for CIN2+ lesions', 'specificity': '62.0% for CIN2+ lesions'}

Background

{'statistics': 'Update with the latest data on cervical cancer incidence and mortality.'}

Data Highlights

{'negative_predictive_value': 'Clarify that this value pertains to the study population.'}

Key Findings

{'DeLong_test': 'Add a sentence explaining the implications of the test results.'}

Clinical Implications

{'limitations': 'Include a discussion on the practical challenges of implementing OITS.'}

Conclusion

{'further_studies': 'Emphasize the need for validation in various demographic groups.'}

Related Resources & Content

  1. Surgical Endoscopy, 2022 -- Utilizing Artificial Intelligence for the Identification of Microvessels in Precancerous Lesions and Early-Stage Esophageal Squamous Cell Carcinomas: A Multicenter Investigation
  2. Classification of Intrapapillary Capillary Loops in Magnified Endoscopy, 2020 -- An Open Dataset and Foundational Methodology
  3. Optometric Management, 2010 -- Faster, More Precise Diagnoses With iTrace Visual Function Analyzer
  4. Draft Recommendation: Cervical Cancer: Screening | United States Preventive Services Taskforce
  5. WHO guideline for screening and treatment of cervical pre-cancer lesions for cervical cancer prevention: use of human papillomavirus (HPV) DNA genotyping
  6. Journal of Gastroenterology — Prospective Multicenter In Vivo Investigation of an Endocytoscope System (ECS) for Treating Superficial Esophageal Carcinoma
  7. Updated Cervical Cancer Screening Guidelines 2025
  8. ASCCP Practice Advisory on Self-Collection for Cervical Cancer Screening
  9. Draft Recommendation: Cervical Cancer: Screening | United States Preventive Services Taskforce
  10. WHO guideline for screening and treatment of cervical pre-cancer lesions for cervical cancer prevention: use of human papillomavirus (HPV) DNA genotyping
  11. :: JGO :: Journal of Gynecologic Oncology
  12. Long-Term Prospective Cohort Study of Cervical Cancer Screening Using Triage of Women Who Are Human Papillomavirus-Positive With Dual Stain and Human Papillomavirus Genotyping - PubMed
  13. Diagnostic testing accuracy of DNA methylation tests for detection of high-grade cervical intraepithelial neoplasia and cervical cancer: A systematic review and meta-analysis - ScienceDirect
  14. Extended Genotyping as Triage of HPV Positive Screened Women in Low‐and‐Middle Income Countries - Merwe - 2026 - Journal of Medical Virology - Wiley Online Library
  15. https://d197for5662m48.cloudfront.net/documents/publicationstatus/270209/preprint_pdf/c76b200b0d7f763dab64ec0dea72833f.pdf
  16. What Are the ASCCP Guidelines? | Cervical Cancer Screening & Management Standards

Original Source(s)

Clinical utility of an optoelectronic imaging tracing system for diagnosis of high-grade cervical lesions

  • by Qianjiao Guo, Lixin Liu, Xiaomin Niu, Haifeng Qiu, Hongjun Guo, Wei Feng, Chunfang Wang, Liya Liu, Zheying Liu, Liping Han

  • June 10, 2026

Related Content

Postop Pain Differs by Vitamin D Status

Patients with preoperative vitamin D deficiency had higher postoperative pain scores and opioid use after mastectomy, including more than triple the odds of moderate to severe pain within 24 hours of surgery.

FDA Approves Expanded Liquid Biopsy Panel

Updated liquid biopsy combines genomic and epigenomic profiling for companion diagnostic use across multiple tumor types.

Case series analysis of immunophenotypic evolution during recurrence of low-grade endometrial stromal sarcoma: implications for molecular stability and clinical management